Genetic and phenotypic characterization of tumor cells derived from malignant peripheral nerve sheath tumors of neurofibromatosis type 1 patients

Neurobiology of Disease

Volumn 16, Issue 1, 2004, Pages 85-91

  Frahm, Silke ^a   Mautner, Victor F ^b   Brems, Hilde ^c   Legius, Eric ^c   Debiec Rychter, Maria ^c   Friedrich, Reinhard E ^a   Knöfel, Wolfram T ^a   Peiper, Matthias ^a   Kluwe, Lan ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Klinik Ochsenzoll   (Germany)

^c CENTER FOR HUMAN GENETICS   (Belgium)

Author keywords

LOH; loss of heterozygosity; malignant peripheral nerve sheath tumor; MPNST; neurofibromatosis type 1; NF1; p16; p53; plexiform neurofibroma; PNF; S100; Schwann cells

Indexed keywords

PROTEIN P16; PROTEIN P53; PROTEIN S 100;

ADULT; ARTICLE; CELL CULTURE; CELL SHAPE; CLINICAL ARTICLE; FEMALE; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; KARYOTYPE; MALE; MORPHOLOGICAL TRAIT; NERVE SHEATH TUMOR; NEUROFIBROMATOSIS; PRIORITY JOURNAL; SCHWANN CELL; TUMOR CELL; TUMOR RECURRENCE;

ADULT; FEMALE; HUMANS; MALE; NERVE SHEATH NEOPLASMS; NEUROFIBROMATOSIS 1; PHENOTYPE; SCHWANN CELLS; TUMOR CELLS, CULTURED;

EID: 2342570393     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2004.01.006     Document Type: Article

References (53)

1. Basu T.N., Gutmann D.H., Fletcher J.A., Glover T.W., Collins F.S., Downward J. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature. 356:1992;713-715
2. Berner J.M., Sorlie T., Mertens F., Henriksen J., Sater G., Mandahl N., Brogger A., Myklebost O., Lothe R.A. Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors: studies of CDKN2A and other genes of the pRB pathway. Genes, Chromosomes Cancer. 26:1999;151-160
3. Birindelli S., Perrone F., Oggionni M., Lavarino C., Pasini B., Vergani B., Ranzani G.N., Pierotti M.A., Pilotti S. Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors. Lab. Invest. 81:2001;833-844
4. Colman S.D., Williams C.A., Wallace M.R. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of NF1 gene. Nat. Genet. 1:1995;90-92
5. Däschner K., Assum G., Eisenbarth I., Krone W., Hoffmeyer S., Wortmann S., Heymer B., Kehrer-Sawatzki H. Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene. Biochem. Biophys. Res. Commun. 234:1997;346-350
6. DeClue J.E., Papageorge A.G., Fletcher J.A., Diehl S.R., Ratner N., Vass W.C., Lowy D.R. Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell. 69:1992;265-273
7. Eisenbarth I., Beyer K., Krone W., Assum G. Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1. Am. J. Hum. Genet. 66:2000;393-401
8. Evans D.G., Baser M.E., McGaughran J., Sharif S., Howard E., Moran A. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J. Med. Genet. 39:2002;311-314
9. Ferner R.E., Gutmann D.H. International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis 1. Cancer Res. 62:2002;1573-1577
10. Glover T.W., Stein C.K., Legius E., Andersen L.B., Brereton A., Johnson S. Molecular and cytogenetic analysis of tumors in von Recklinghausen neurofibromatosis. Genes, Chromosomes Cancer. 3:1991;62-70
11. Gutmann D.H., Collins F.S. Neurofibromatosis type 1. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The Metabolic and Molecular Bases of Inherited Disease. 1995;76-96 McGraw-Hill, New York
12. Gutmann D.H., Wood D.L., Collins F.S. Identification of the neurofibromatosis type 1 gene product. Proc. Natl. Acad. Sci. 88:1991;9658-9662
13. Gutmann D.H., Cole J.L., Stone W.J., Ponder B.A.J., Collins F.S. Loss of neurofibromin in adrenal gland tumors from patients with neurofibromatosis type 1. Genes, Chromosomes Cancer. 10:1994;55-58
14. Gutmann D.H., Aylsworth A., Carey J.C., Korf B., Marks J., Pyeritz R.E., Rubenstein A., Viskochil D. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA. 278:1997;51-57
15. Huson S.M. Recent developments in the diagnosis and management of neurofibromatosis. Arch. Dis. Child. 64:1989;745-749
16. John A.M., Ruggieri M., Ferner R., Upadhyaya M. A search for evidence of somatic mutations in the NF1 gene. J. Med. Genet. 37:2000;44-49
17. Kluwe L., Friedrich R.E., Mautner V.F. Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas. Cancer Genet. Cytogenet. 113:1999;65-69
18. Kluwe L., Friedrich R.E., Mautner V.F. Loss of NF1 allele in Schwann cells but not in fibroblasts derived from an NF1-associated neurofibroma. Genes, Chromosomes Cancer. 24:1999;283-285
19. Kluwe L., Friedrich R.E., Korf B., Fahsold R., Mautner V.F. NF1 mutations in neurofibromatosis 1 patients with plexiform neurofibromas. Hum. Mutat. 19:2002;309
20. Kourea H.P., Orlow I., Scheithauer B.W., Cordon-Cardo C., Woodruff J.M. Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas. Am. J. Pathol. 155:1999;1855-1860
21. Legius E., Marchuk D.A., Collins F.S., Glover T.W. Somatic deletion of neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumor suppressor gene hypothesis. Nat. Genet. 3:1993;122-126
22. Legius E., Dierick H., Wu R., Hall B.K., Marynen P., Cassiman J.J., Glover T.W. TP53 mutations are frequent in malignant NF1 tumors. Genes, Chromosomes Cancer. 10:1994;250-255
23. Lopez-Correa C., Brems H., Lázaro C., Estivill X., Clementi M., Mason S., Rutkowski J.L., Marynen P., Legius E. Molecular studies in 20 submicroscopic neurofibromatosis type 1 gene deletions. Hum. Mutat. 14:1999;387-393
24. Lothe R.A., Saeter G., Danielsen H., Stenwig A.E., Hoyheim B., O'Connell B., Borresen A.L. Genetic alterations in a malignant schwannoma from a patient with neurofibromatosis (NF1). Pathol., Res. Pract. 189:1993;465-471
25. Lothe R.A., Slettan A., Saeter G., Brogger A., Borresen A.L., Nesland J.M. Alterations at chromosome 17 loci in peripheral nerve sheath tumors. J. Neuropathol. Exp. Neurol. 54:1995;65-73
26. Martinsson T., Sjoberg R.M., Hedborg F., Kogner P. Homozygous deletion of the neurofibromatosis-1 gene in the tumor of a patient with neuroblastoma. Cancer Genet. Cytogenet. 95:1997;183-189
27. Menon A.G., Anderson K.M., Riccardi V.M., Chung R.Y., Whaley J.M., Ledbetter D.H., Kleider A., Martuza R., Gusella J.F., Seizinger B.R. Chromosome 17p deletions and p53 mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc. Natl. Acad. Sci. U. S. A. 87:1990;5435-5439
28. Metheny L.J., Cappione A.J., Skuse G.R. Genetic and epigenetic mechanisms in the pathogenesis of neurofibromatosis type 1. J. Neuropathol. Exp. Neurol. 54:1995;753-760
29. Muir D., Neubauer D., Lim I.T., Yachnis A.T., Wallace M.R. Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells. Am. J. Pathol. 158:2001;501-513
30. Nielson G.P., Stemmer-Rachmaninov A.O., Ino Y., Moller M.B., Rosenberg A.E., Louis D.N. Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation. Am. J. Pathol. 155:1999;1879-1884
31. Peltonen J., Jaakola S., Lebwohl M. Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab. Invest. 59:1988;760-771
32. Perry A., Roth K.A., Banerjee R., Fuller C.E., Gutmann D.H. NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors. Am. J. Pathol. 159:2001;57-61
33. Poyhonen M., Kytola S., Leisti J. Epidemiology of neurofibromatosis type 1 (NF1) in northern Finland. J. Med. Genet. 37:2000;632-636
34. Rasmussen S.A., Friedman J.M. NF1 gene and neurofibromatosis 1. Am. J. Epidemiol. 151:2000;33-40
35. Rasmussen S.A., Overman J., Thomson S.A.M., Colman S.D., Abernathy C.R., Trimpert R.E., Moose R., Virdi G., Roux K., Bauer M., Rojiani A.M., Maria B.L., Muir D., Wallace M.R. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1. Genes, Chromosomes Cancer. 28:2000;425-431
36. Riccardi V.M. Neurofibromatosis: Phenotype, Natural History and Pathogenesis. Second ed. 1992;John Hopkins Univ. Press, Baltimore, MD
37. Rutkowski J.L., Tennekoon G.I., McGillicuddy J.E. Selective culture of mitotically active human Schwann cells in vitro. Nat. Med. 1:1992;80-83
38. Rutkowski J.L., Wu K., Gutmann D.H., Boyer P.J., Legius E. Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1. Hum. Mol. Genet. 9:2000;1059-1066
39. Sawada S., Florell S., Purandare S.M., Ota M., Stephens K., Viskochil D. Identification of NF1 mutations in both alleles of a dermal neurofibroma. Nat. Genet. 14:1996;110-112
40. Scheithauer B.W., Woodruff J.M., Erlandson R.A. Neurofibroma. Tumors of the peripheral nervous system. Atlas of Tumor Pathology, Third Series. 1999;177-218 Armed Forces Institute of Pathology, Washington, DC. Fascicle 24
41. Serra E., Puig S., Otero D., Gaona A., Kruyer H., Ars E., Estivill X., Lazaro C. Confirmation of a double-hit model for the NF1 gene in benign neurofibromas. Am. J. Hum. Genet. 61:1997;512-519
42. Serra E., Rosenbaum T., Winner U., Aledo R., Ars E., Estivill X., Lenard H.G., Lazaro C. Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations. Hum. Mol. Genet. 20:2000;3055-3064
43. Serra E., Ars E., Ravella A., Sánchez A., Puig S., Rosenbaum T., Estivill X., Lázaro C. Somatic NF1 mutational spectrum in benign neurofibromas: mRNA splice defects are common among point mutations. Hum. Genet. 108:2001;416-429
44. Shannon K.M., O'Connell P., Martin G.A., Paderanga D., Olson K., Dinndorf P., McCormick F. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N. Engl. J. Med. 330:1994;597-601
45. Side L., Taylor B., Cayouette M., Conner E., Thompson P., Luce M., Shannon K. Homozygous inactivation of NF1 in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. N. Engl. J. Med. 336:1997;1713-1720
46. Skuse G.R., Kosciolek B.A., Rowley P.T. Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis. Genes, Chromosomes Cancer. 1:1989;36-41
47. Topsakal C., Akdemir I., Tiftikci M., Ozercan I., Aydin Y. Malignant schwannoma of the sciatic nerve originating in a spinal plexiform neurofibroma associated with neurofibromatosis type 1 - Case report. Neurol. Med.-Chir. (Tokyo). 41:2001;551-555
48. Viskochil D., Buchberg A.M., Xu G., Stevens J., Wolff R.K., Culver M., Carey J.C., Copeland N.G., Jenkins N.A., White R., O'Connel P. Deletions and translocations interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell. 62:1990;187-192
49. Vogel K., Klesse L.J., Velasco-Miguel S., Meyers K., Rushing E.J., Parada L.F. Mouse tumor model for neurofibromatosis type 1. Science. 286:1999;2176-2179
50. Wallace M.R., Marchuk D.A., Andersen L.B., Letcher R., Oden H.M., Saulino H.M., Fountain J.W., Brereton A.M., Nicholson J., Mitchell A.L., Brownstein B.H., Collins F.S. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science. 249:1990;181-186
51. Wallace M.R., Rasmussen S.A., Lim I.T., Bray B.A., Zori R.T., Muir D. Culture of cytogenetically abnormal Schwann cells from benign and malignant NF1 tumors. Genes, Chromosomes Cancer. 27:2000;117-123
52. Weiss S.W., Langloss J.M., Enzinger F.M. Value of S-100 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant Schwann cell tumors. Lab. Invest. 49:1983;299-308
53. Woodruff J.M., Kourea H.P., Louis D.N., Scheithauer B.W. Malignant peripheral nerve sheath tumour. Kleihues P., Cavanee W.K. WHO Classification: Tumours of the Nervous System. 2000;172-174 IARC Press, Lyon